RWE Day
Connecting Data, Evidence and Governance
A day to bring together the key players of the health ecosystem — industry, regulators, data providers and academia — and discuss how Real-World Evidence is transforming the way data is structured, evidence is generated and decisions are made.
Accelerating innovation in Life Science and Healthcare through real-world data
An in-person session dedicated to Real-World Evidence, data-driven insights and privacy aspects in today's healthcare context.
See the editionRWE Day 2026 — the event video
Relive the highlights, the talks and the conversations that marked the first edition.
A journey in two moments: building the data foundation and using evidence strategically
In a global scenario where real-world data is becoming a pillar of healthcare innovation, RWE Day proposes a journey structured in two complementary blocks.
The RWE foundation: data, standardization and scalability
Dedicated to data-providing institutions: the challenges and advances in structuring, standardizing and governing real-world clinical data. Federated analysis and Common Data Models (CDM) as enablers of large-scale integration without centralization — with DARWIN-EU and EHDEN as key references.
- Interoperability and comparability across databases
- Scalability across continental territories
- Privacy preservation and local data governance
- Complementarity between different types of clinical data
Premise: there is no robust evidence without structured, standardized and governed data.
From evidence to decision: regulation, industry and health impact
How structured data becomes evidence used strategically by industry, regulators and policy makers — in the context of recent advances by FDA and EMA, which increasingly incorporate RWE into health technology assessment.
- RWE to complement clinical trials
- Support for regulatory approval and label expansion
- Evidence for access and reimbursement decisions
- Post-marketing studies and pharmacovigilance
Message: RWE is no longer complementary — it has become a central strategic asset in healthcare decision-making.
RWE Day positions itself as a space to discuss not only the present but, above all, the future of real-world data use in Brazil and Latin America — aligned with global best practices.
Accelerating innovation in Life Science and Healthcare through real-world data
An in-person session dedicated to exploring Real-World Evidence (RWE), data-driven insights, its role in clinical and regulatory decision-making and data privacy aspects in today's healthcare context.
OMOP CDM for RWE in the regulatory context
Health data standardization with the OMOP model to enable RWE studies with quality, transparency and regulatory compliance — robust, reproducible analyses.
Federated architecture for LGPD compliance
A federated approach that enables clinical data analysis without sharing sensitive data, ensuring privacy, security and compliance throughout the analytical cycle.
AI for data analysis on the Precision Data Platform
Artificial intelligence integrated into the platform to accelerate health data analysis, generate advanced insights and expand user autonomy without programming.
From the RWE Intensive to RWE Day: building the RWE ecosystem
Best scientific work in the Clinical Application category. See
Open lecture series on Real-World Evidence on our channel. Watch
First in-person edition: regulatory OMOP, LGPD federation and AI. Video
Participation and organization with the OHDSI LATAM community in Salvador.
Being planned. Leave your contact to receive the agenda first.
Want to be at the next RWE Day?
As a participant, speaker, data provider or sponsor — tell us how you want to join the conversation.